Yes, for a while. Ibuprofen is an anti-inflammatory drug. It blocks the enzyme that makes prostaglandins, chemical messengers that drive swelling and pain. It works well for short-term pain. But long-term, low-grade inflammation is linked to inactivity, diet and stress, which a pill doesn't change. And high doses raise the risk of stomach bleeding and heart problems.
How does ibuprofen reduce inflammation?
Ibuprofen belongs to a group of drugs called NSAIDs, short for nonsteroidal anti-inflammatory drugs. They all block an enzyme called cyclooxygenase, or COX.
COX turns a fat in your cells into prostaglandins. These are short-lived chemical messengers. Some keep the body running day to day. Others drive the swelling, heat and pain of inflammation. Block COX, and fewer of them get made.
Here is the catch. A 2011 review notes that prostaglandins may also help end inflammation, not just start it.
Is ibuprofen an anti-inflammatory medicine that actually works?
For short-term pain, yes, and the evidence is strong. A 2015 Cochrane overview pulled together trial data on over-the-counter painkillers, mostly from people who had just had a wisdom tooth pulled. Fast-acting ibuprofen at 200 or 400 mg gave at least half pain relief to more than half of people. Aspirin and acetaminophen (also called paracetamol) did worse, with success rates of 11% to 43%. Side effects were mostly no different from a dummy pill.
Short bursts of inflammation are critical for survival after injury and infection.From a 2019 review in Nat Med
Arthritis is a longer job. A 2021 network meta-analysis pooled 192 trials with 102,829 people with knee or hip arthritis. Some oral NSAIDs eased pain by a clear amount, but the authors said they are "probably not appropriate" for long-term use or for people with other health problems, because of side effects. Rub-on NSAID gels did well with no added risk of side effects, and the authors called them a first choice for knee arthritis.
Does ibuprofen reduce long-term, low-grade inflammation?
There are two kinds of "inflammation" that are easy to mix up.
The first is the quick, hot kind. You twist a knee, it swells, and in a week or two it settles. That burst is part of healing. A 2019 review in Nature Medicine says short bursts of inflammation are "critical for survival" after injury and infection.
The second is slow and quiet. Scientists call it systemic chronic inflammation. It builds over years and is linked to heart disease, diabetes, kidney disease and more. The same review lists what tends to drive it: too little movement, a poor diet, ongoing stress, infections and pollution. Ibuprofen changes none of those.
We found no trials showing that daily ibuprofen lowers that slow, body-wide inflammation. The few clues we did find point the other way. In a 2006 study of 54 runners in a 160-km race, the 29 who took ibuprofen had bigger rises in CRP and IL-6 than the 25 who took nothing. CRP (C-reactive protein) and IL-6 are proteins in the blood that rise with inflammation. The runners on ibuprofen were not less sore afterward, either. That was one study of extreme exercise, and runners chose for themselves whether to take the drug, so it can't show cause and effect.
Can blocking inflammation get in the way?
Sometimes it seems to. In a 2018 randomized trial, 31 young adults lifted weights for 8 weeks. Half took 1,200 mg of ibuprofen a day, the top over-the-counter dose. The others took a low-dose aspirin. Thigh muscle grew 7.5% in the aspirin group and 3.7% in the ibuprofen group. A follow-up study on the same kind of training could not find out why. A 2018 review says NSAIDs "have been reported to interfere" with muscle and strength gains in young people.
Pain may follow a similar pattern. A 2022 study tracked 98 people with fresh low back pain for 3 months. Those whose pain went away showed a short burst of inflammation driven by white blood cells called neutrophils. Those whose pain lasted did not. In mice, early anti-inflammatory drugs eased pain at first but made it last longer. In a large UK health database, taking NSAIDs was linked to a higher risk of back pain that didn't go away. Mouse results and database links are early clues, not proof. Still, they fit the idea that some inflammation is doing a job.
The trade-off: your stomach and heart
Some prostaglandins do everyday upkeep, so blocking them has costs. A 2013 meta-analysis in The Lancet pooled 280 trials of NSAIDs against a placebo, with 124,513 people. At the high doses used in those trials, ibuprofen was linked to about four times more serious stomach problems, such as bleeding or a hole in the stomach wall. Every NSAID roughly doubled the risk of heart failure. Ibuprofen also raised the risk of major heart events.
Dose and time matter. A 2025 meta-analysis of 17 studies with 89,522 people found ibuprofen linked to more stomach bleeding than taking nothing. But low doses for a short time were not linked to more bleeding than acetaminophen. The certainty of that evidence was very low.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you take a blood thinner, daily aspirin or blood pressure medicine, have had a stomach ulcer or bleeding, have heart, kidney or liver disease, have asthma that flares with pain relievers, are pregnant, or need a pain reliever for more than a few days.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
A swollen ankle, a runner's blood test and a back that wouldn't settle tell the same story. Ibuprofen is a real anti-inflammatory, and it is good at the short, hot kind of pain. But the slow inflammation linked to heart disease and diabetes is linked to how we move, eat and handle stress. A pill can quiet the signal. It can't change the source. Keep ibuprofen for the sprains and the bad days, and put the daily effort into the habits behind the slow kind.
Common questions
Is ibuprofen an anti-inflammatory medicine?
Yes. Ibuprofen is an NSAID, a nonsteroidal anti-inflammatory drug. It blocks the COX enzyme, so the body makes fewer prostaglandins, the messengers behind swelling and pain. Acetaminophen is different: it may ease pain partly through other pathways in the brain. For short-term pain, fast-acting 200 and 400 mg doses worked for more than half of people in trials.
What is the anti-inflammatory dose of ibuprofen?
The research we checked gives no single anti-inflammatory dose. For short-term pain, 200 and 400 mg fast-acting doses worked well. In a weight training trial, 1,200 mg a day was called the "maximal over-the-counter" dose, and it cut muscle growth. Higher doses in large trials brought more stomach and heart risk. Follow the label, and ask a doctor about anything longer.
Does ibuprofen cause inflammation in the stomach?
Not inflammation as such, but it can hurt the stomach. In a meta-analysis of 280 trials, high-dose ibuprofen was linked to about four times more serious stomach problems, such as bleeding or a hole in the stomach wall. A 2025 review found low doses for a short time were not linked to more bleeding than acetaminophen, though that evidence was weak. It is one more reason to keep the dose low and the course short.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 12 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 31, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- ReviewProstaglandins and inflammation.Ricciotti E, FitzGerald GA Arterioscler Thromb Vasc Biol, 2011.PubMedFull paper
- Systematic reviewNon-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews.Moore RA, Wiffen PJ, Derry S et al. Cochrane Database Syst Rev, 2015.PubMedFull paper
- Meta-analysisEffectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.da Costa BR, Pereira TV, Saadat P et al. BMJ, 2021.PubMedFull paper
- ReviewChronic inflammation in the etiology of disease across the life span.Furman D, Campisi J, Verdin E et al. Nat Med, 2019.PubMedFull paper
- StudyIbuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition.Nieman DC, Henson DA, Dumke CL et al. Brain Behav Immun, 2006.PubMedFull paper
- Randomized trialHigh doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults.Lilja M, Mandić M, Apró W et al. Acta Physiol (Oxf), 2018.PubMedFull paper
- Randomized trialLimited effect of over-the-counter doses of ibuprofen on mechanisms regulating muscle hypertrophy during resistance training in young adults.Lilja M, Moberg M, Apró W et al. J Appl Physiol (1985), 2023.PubMedFull paper
- ReviewAnalgesic and anti-inflammatory drugs in sports: Implications for exercise performance and training adaptations.Lundberg TR, Howatson G Scand J Med Sci Sports, 2018.PubMedFull paper
- CohortAcute inflammatory response via neutrophil activation protects against the development of chronic pain.Parisien M, Lima LV, Dagostino C et al. Sci Transl Med, 2022.PubMedFull paper
- Meta-analysisVascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.Bhala N, Emberson J, Merhi A et al. Lancet, 2013.PubMedFull paper
- Meta-analysisIs ibuprofen associated with upper gastrointestinal bleeding? A systematic review and meta-analysis.Gkiouras K, Myrogiannis I, Kouvelas D Inflammopharmacology, 2025.PubMedFull paper
- Systematic reviewPharmacological bases of combining nonsteroidal antiinflammatory drugs and paracetamol.Tena-Garitaonaindia M, Rubio JM, Martínez-Plata E et al. Biomed Pharmacother, 2025.PubMedFull paper
